Cargando…
Once-a-Day Ceftriaxone–Amikacin Combination as Empiric Antibiotic Therapy to Enable Outpatient Management of Febrile Neutropenia in Children—16-Year Experience from a Single Institute
Background To enable outpatient department (OPD) management of febrile neutropenia (FN), we used once-a-day (OD) ceftriaxone–amikacin (CFT-AMK) as empiric antibiotic therapy. Our experience over 16-year period is presented. Methods This was a retrospective study conducted from January2002 to Decem...
Autores principales: | Kanvinde, Shailesh, Mulay, Atul, Deshpande, Anand, Deshmukh, Chetan, Patwardhan, Sampada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902091/ https://www.ncbi.nlm.nih.gov/pubmed/36756094 http://dx.doi.org/10.1055/s-0042-1745834 |
Ejemplares similares
-
Meta-analysis: combination of meropenem vs ceftazidime and amikacin for empirical treatment of cancer patients with febrile neutropenia
por: Wang, Ying, et al.
Publicado: (2021) -
Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018) -
Outpatient management of febrile neutropenia in children with cancer
por: Ziino, Ottavio, et al.
Publicado: (2011) -
Consensus on diagnosis and empiric antibiotic therapy of febrile neutropenia
por: Giurici, Nagua, et al.
Publicado: (2011) -
A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients
por: Kamonrattana, Ruchirek, et al.
Publicado: (2019)